Related Experiment Video
Updated: Jul 2, 2026

Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Anti-inflammatory effects of m-chlorophenylpiperazine in brain glia cells
Jaegyu Hwang1, Long Tai Zheng, Jiyeon Ock
1Department of Pharmacology, School of Medicine, Brain Science and Engineering Institute, CMRI, Kyungpook National University, Daegu, South Korea.
Abstract:
Glia cells are regarded as a mediator of neuroinflammation releasing pro-inflammatory cytokines and nitric oxide in the central nervous system. Microglia and astrocytes have been reported to play an important role in the progression of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. m-Chlorophenylpiperazine (m-CPP) is used clinically to manipulate serotonergic function, though its precise mechanisms of actions are not well understood. m-CPP alters synaptic transmission and neuronal function in vertebrates by non-selective agonistic actions on 5-HT1 and 5-HT2 receptors. In the present study, the anti-inflammatory effect of m-CPP was investigated in lipopolysaccharide (LPS)-stimulated microglia and astrocyte cultures. Our results showed that m-CPP significantly decreased the production of nitric oxide, tumor necrosis factor-alpha (TNF-alpha), and interleukin-1beta (IL-1beta) in microglia and astrocyte cultures. m-CPP also attenuated the expression of inducible nitric oxide synthase and pro-inflammatory cytokines such as IL-1beta and TNF-alpha at mRNA levels. In addition, m-CPP inhibited nuclear factor-kappa B activation and phosphorylation of p38 mitogen-activated protein kinase in the LPS-stimulated microglia cells, providing molecular mechanisms of the anti-inflammatory effects. Moreover, m-CPP was neuroprotective as the drug reduced microglia-mediated neuroblastoma cell death in a microglia-neuron co-culture. These findings suggest that m-CPP may have important implications in the treatment of neuroinflammatory diseases.
Insights
m-Chlorophenylpiperazine (m-CPP) reduces neuroinflammation by decreasing pro-inflammatory factors in glia cells. This drug also demonstrated neuroprotective effects, suggesting potential for treating neuroinflammatory diseases.
Area of Science:
- Neuroscience
- Neuroinflammation
- Pharmacology
Background:
- Glia cells, including microglia and astrocytes, mediate neuroinflammation and are implicated in neurodegenerative diseases like Alzheimer's and Parkinson's.
- m-Chlorophenylpiperazine (m-CPP) is a drug that affects serotonergic function via 5-HT1 and 5-HT2 receptors, but its anti-inflammatory mechanisms are unclear.
Purpose of the Study:
- To investigate the anti-inflammatory effects of m-CPP in lipopolysaccharide (LPS)-stimulated microglia and astrocyte cultures.
- To elucidate the molecular mechanisms underlying m-CPP's anti-inflammatory actions.
- To assess the neuroprotective potential of m-CPP in a microglia-neuron co-culture model.
Main Methods:
- Primary cell cultures of microglia and astrocytes were stimulated with LPS.
- Treatment with m-CPP was applied to assess its impact on nitric oxide (NO), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1beta (IL-1beta) production.
- Gene expression of inducible nitric oxide synthase (iNOS) and pro-inflammatory cytokines was analyzed.
- Nuclear factor-kappa B (NF-kappa B) activation and p38 mitogen-activated protein kinase (MAPK) phosphorylation were assessed.
- A microglia-neuron co-culture system was used to evaluate neuroprotection.
Main Results:
- m-CPP significantly reduced the production of NO, TNF-alpha, and IL-1beta in LPS-stimulated microglia and astrocytes.
- m-CPP attenuated the mRNA expression of iNOS, IL-1beta, and TNF-alpha.
- m-CPP inhibited NF-kappa B activation and p38 MAPK phosphorylation in LPS-stimulated microglia.
- m-CPP demonstrated neuroprotective effects by reducing microglia-mediated neuroblastoma cell death.
Conclusions:
- m-CPP exhibits significant anti-inflammatory effects in microglia and astrocytes.
- The anti-inflammatory actions of m-CPP are mediated through the inhibition of NF-kappa B and p38 MAPK pathways.
- m-CPP possesses neuroprotective properties, suggesting its therapeutic potential for neuroinflammatory conditions.
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction

